367 related articles for article (PubMed ID: 1793735)
1. Interferon regulatory factor 1 is a myeloid differentiation primary response gene induced by interleukin 6 and leukemia inhibitory factor: role in growth inhibition.
Abdollahi A; Lord KA; Hoffman-Liebermann B; Liebermann DA
Cell Growth Differ; 1991 Aug; 2(8):401-7. PubMed ID: 1793735
[TBL] [Abstract][Full Text] [Related]
2. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
Liebermann DA; Hoffman B
Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
[TBL] [Abstract][Full Text] [Related]
3. Dissection of the immediate early response of myeloid leukemia cells to terminal differentiation and growth inhibitory stimuli.
Lord KA; Abdollahi A; Hoffman-Liebermann B; Liebermann DA
Cell Growth Differ; 1990 Dec; 1(12):637-45. PubMed ID: 2126951
[TBL] [Abstract][Full Text] [Related]
4. Transient expression of the IL-2 receptor alpha-chain in IL-6-induced myeloid cells is regulated by autocrine production of prostaglandin E2.
Ruhl S; Begley CG; Bickel M; Pluznik DH
Exp Hematol; 1992 Jun; 20(5):619-25. PubMed ID: 1587308
[TBL] [Abstract][Full Text] [Related]
5. The role of interferon regulatory factor-1 in cytokine-induced mRNA expression and cell death in murine pancreatic beta-cells.
Pavlovic D; Chen MC; Gysemans CA; Mathieu C; Eizirik DL
Eur Cytokine Netw; 1999 Sep; 10(3):403-12. PubMed ID: 10477397
[TBL] [Abstract][Full Text] [Related]
6. Inhibition by interleukin 4 of leukemia inhibitory factor-, interleukin 6-, and dexamethasone-induced differentiation of mouse myeloid leukemia cells: role of c-myc and junB proto-oncogenes.
Kasukabe T; Okabe-Kado J; Hozumi M; Honma Y
Cancer Res; 1994 Jan; 54(2):592-7. PubMed ID: 8275499
[TBL] [Abstract][Full Text] [Related]
7. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.
Onozaki K; Urawa H; Tamatani T; Iwamura Y; Hashimoto T; Baba T; Suzuki H; Yamada M; Yamamoto S; Oppenheim JJ
J Immunol; 1988 Jan; 140(1):112-9. PubMed ID: 3275716
[TBL] [Abstract][Full Text] [Related]
8. Murine flt3 ligand protects M1 leukemic cells from LIF-induced differentiation and suppression of self-renewal.
Begley CG; Rasko JE; Curtis D; Takagi K; Metcalf D; Hilton D; Roberts B; Nicola NA; Rossner MT
Exp Hematol; 1996 Aug; 24(10):1247-57. PubMed ID: 8765501
[TBL] [Abstract][Full Text] [Related]
9. Sequence and expression of a cDNA encoding MyD118: a novel myeloid differentiation primary response gene induced by multiple cytokines.
Abdollahi A; Lord KA; Hoffman-Liebermann B; Liebermann DA
Oncogene; 1991 Jan; 6(1):165-7. PubMed ID: 1899477
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 6 induces DNA binding activity of AP1 in M1 myeloblastic cells but not in a growth resistant cell derivative.
Melamed D; Resnitzky D; Haimov I; Levy N; Pfarr CM; Yaniv M; Kimchi A
Cell Growth Differ; 1993 Aug; 4(8):689-97. PubMed ID: 8398910
[TBL] [Abstract][Full Text] [Related]
11. IFI 16 gene encodes a nuclear protein whose expression is induced by interferons in human myeloid leukaemia cell lines.
Dawson MJ; Trapani JA
J Cell Biochem; 1995 Jan; 57(1):39-51. PubMed ID: 7536752
[TBL] [Abstract][Full Text] [Related]
12. In vitro expansion of murine hematopoietic progenitor cells by leukemia inhibitory factor, stem cell factor, and interleukin-1 beta.
Imamura M; Zhu X; Han M; Kobayashi M; Hashino S; Tanaka J; Kobayashi S; Kasai M; Asaka M
Exp Hematol; 1996 Sep; 24(11):1280-8. PubMed ID: 8862438
[TBL] [Abstract][Full Text] [Related]
13. Complexity of the immediate early response of myeloid cells to terminal differentiation and growth arrest includes ICAM-1, Jun-B and histone variants.
Lord KA; Hoffman-Liebermann B; Liebermann DA
Oncogene; 1990 Mar; 5(3):387-96. PubMed ID: 1690380
[TBL] [Abstract][Full Text] [Related]
14. Induction of transcription factor interferon regulatory factor-1 by interferon-gamma (IFN gamma) and tumor necrosis factor-alpha (TNF alpha) in FRTL-5 cells.
Mori K; Stone S; Khaodhiar L; Braverman LE; DeVito WJ
J Cell Biochem; 1999 Aug; 74(2):211-9. PubMed ID: 10404391
[TBL] [Abstract][Full Text] [Related]
15. Expression of BCR - ABL in M1 myeloid leukemia cells induces differentiation without arresting proliferation.
Cambier N; Zhang Y; Vairo G; Kosmopoulos K; Metcalf D; Nicola NA; Elefanty AG
Oncogene; 1999 Jan; 18(2):343-52. PubMed ID: 9927191
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-4 (IL-4) in combination with IL-11 or IL-6 reverses the inhibitory effect of IL-3 on early B lymphocyte development.
Neben S; Donaldson D; Fitz L; Calvetti J; Neben T; Turner K; Hirayama F; Ogawa M
Exp Hematol; 1996 Jun; 24(7):783-9. PubMed ID: 8647228
[TBL] [Abstract][Full Text] [Related]
17. Effects of transforming growth factor beta, tumor necrosis factor alpha, interferon gamma and LIF-HILDA on the proliferation of acute myeloid leukemia cells.
Kerangueven F; Sempere C; Tabilio A; Mannoni P
Eur Cytokine Netw; 1990; 1(2):99-107. PubMed ID: 2129395
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid resistance in NB4 APL cells is associated with lack of interferon alpha synthesis Stat1 and p48 induction.
Pelicano L; Brumpt C; Pitha PM; Chelbi-Alix MK
Oncogene; 1999 Jul; 18(27):3944-53. PubMed ID: 10435617
[TBL] [Abstract][Full Text] [Related]
19. Unmasking by soluble IL-6 receptor of IL-6 effect on metastatic melanoma: growth inhibition and differentiation of B16-F10.9 tumor cells.
Oh JW; Katz A; Harroch S; Eisenbach L; Revel M; Chebath J
Oncogene; 1997 Jul; 15(5):569-77. PubMed ID: 9247310
[TBL] [Abstract][Full Text] [Related]
20. Proto-oncogene expression and dissection of the myeloid growth to differentiation developmental cascade.
Liebermann DA; Hoffman-Liebermann B
Oncogene; 1989 May; 4(5):583-92. PubMed ID: 2471131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
